Opportunity Information: Apply for RFA MD 17 001
Innovations for Healthy Living - Improving Population Health and Eliminating Health Disparities (R43/R44) is a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) funding opportunity that supports U.S. small business concerns developing commercially viable solutions that can reduce health disparities and improve population health. The central focus is on creating a product, process, or service that can be brought to market and that measurably improves healthcare access, health outcomes, disease prevention, or overall health for one or more NIH-defined health disparity population groups. In practice, this means proposed innovations should be designed with the realities of underserved communities in mind, including the barriers that drive unequal outcomes across groups such as racial and ethnic minorities, people with low incomes, and rural populations.
The FOA emphasizes that proposed technologies and approaches should not only be scientifically and technically sound, but also practical for real-world adoption in communities experiencing disparities. NIH highlights several characteristics that matter for these innovations: they should be effective (able to demonstrate meaningful benefit), affordable (priced or structured so that cost is not a primary barrier), culturally acceptable (aligned with the values, language, norms, and preferences of the intended users), and deliverable (feasible to deploy in settings where resources, infrastructure, workforce, transportation, broadband, or specialty care access may be limited). The commercial angle is important: applicants are expected to be building something with a clear pathway to market so that the innovation can scale and sustain impact beyond the grant period.
This opportunity uses the SBIR mechanisms R43 and R44, which generally correspond to phased small-business R and D funding. While the FOA text provided does not list award amounts or the number of expected awards, the structure of R43/R44 signals support for early-stage development through later-stage refinement toward commercialization, with an expectation that the work will progress from development and feasibility toward a more complete, market-ready solution. The overall activity category is Health, and the related CFDA (assistance listing) number is 93.307, which is commonly associated with NIH small business programs.
Eligibility is limited to U.S. small business concerns. Foreign institutions (non-U.S. entities) are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible. At the same time, the announcement notes that foreign components may be allowed as defined by the NIH Grants Policy Statement, meaning certain project elements might be conducted outside the United States if they meet NIH policy requirements and are justified, but the applicant organization itself must still qualify as an eligible U.S. small business.
Key administrative details in the source data include the funding opportunity number RFA-MD-17-001, the agency NIH, an opportunity category of discretionary funding, and an original closing date of 2017-02-22. The opportunity was created on 2016-12-12. Overall, the FOA is aimed at driving innovation that directly addresses unequal health burdens by supporting small businesses building solutions that are not only innovative but also realistically adoptable in underserved communities where affordability, cultural fit, and delivery constraints can determine whether an intervention succeeds or fails.Apply for RFA MD 17 001
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Innovations for Healthy Living - Improving Population Health and Eliminating Health Disparities (R43/R44)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.307.
- This funding opportunity was created on 2016-12-12.
- Applicants must submit their applications by 2017-02-22. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the "Innovations for Healthy Living - Improving Population Health and Eliminating Health Disparities (R43/R44)" opportunity?
It is a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) funding opportunity that supports U.S. small business concerns developing commercially viable solutions to reduce health disparities and improve population health.
Which agency is offering this funding opportunity?
The funding opportunity is offered by the National Institutes of Health (NIH).
What is the funding mechanism for this opportunity?
This opportunity uses the NIH SBIR mechanisms R43 and R44, which generally support phased small-business research and development (R&D), typically moving from early development/feasibility toward later-stage refinement and commercialization.
What types of projects does this FOA aim to support?
The FOA aims to support innovations that result in a product, process, or service that can be brought to market and that measurably improves healthcare access, health outcomes, disease prevention, or overall health for one or more NIH-defined health disparity population groups.
Is commercialization an important part of this opportunity?
Yes. The FOA emphasizes a clear pathway to market so the innovation can scale and sustain impact beyond the grant period.
Who is eligible to apply?
Eligibility is limited to U.S. small business concerns.
Are foreign institutions eligible to apply?
No. Foreign institutions (non-U.S. entities) are not eligible to apply.
Are non-domestic components of U.S. organizations eligible?
No. Non-domestic components of U.S. organizations are not eligible.
Can any part of the work be conducted outside the United States?
The announcement notes that foreign components may be allowed as defined by the NIH Grants Policy Statement, meaning certain project elements might be conducted outside the U.S. if they meet NIH policy requirements and are justified, while the applicant organization must still be an eligible U.S. small business.
What populations is this FOA focused on?
The FOA targets NIH-defined health disparity population groups and emphasizes designing for underserved communities. Examples mentioned include racial and ethnic minorities, people with low incomes, and rural populations.
What outcomes should the innovation improve?
The innovation should measurably improve one or more of the following: healthcare access, health outcomes, disease prevention, or overall health for one or more health disparity population groups.
What qualities does NIH emphasize for proposed innovations?
NIH highlights that innovations should be scientifically and technically sound, and also practical for real-world adoption. The FOA emphasizes that solutions should be effective, affordable, culturally acceptable, and deliverable in resource-limited settings.
What does "effective" mean in the context of this FOA?
Effective means the innovation should be able to demonstrate meaningful benefit for the intended users or communities experiencing health disparities.
What does "affordable" mean in the context of this FOA?
Affordable means the innovation should be priced or structured so that cost is not a primary barrier for the intended population or setting.
What does "culturally acceptable" mean in the context of this FOA?
Culturally acceptable means the innovation should align with the values, language, norms, and preferences of the intended users.
What does "deliverable" mean in the context of this FOA?
Deliverable means the innovation should be feasible to deploy in real-world settings where resources, infrastructure, workforce, transportation, broadband, or specialty care access may be limited.
What is the opportunity category?
The opportunity category is discretionary funding.
What is the activity category for this FOA?
The overall activity category is Health.
What is the funding opportunity number?
The funding opportunity number is RFA-MD-17-001.
What is the related CFDA (Assistance Listing) number?
The related CFDA (assistance listing) number is 93.307.
When was this opportunity created?
The opportunity was created on 2016-12-12.
What was the original closing date for this opportunity?
The original closing date listed is 2017-02-22.
Does the provided FOA information include award amounts or the expected number of awards?
No. The provided text does not list award amounts or the number of expected awards.
What stage of development is this funding intended to support?
Based on the R43/R44 structure, the opportunity is intended to support early-stage development and feasibility through later-stage refinement toward a more complete, market-ready solution.
What is the overall goal of the FOA?
The FOA is aimed at driving innovation that directly addresses unequal health burdens by supporting small businesses building solutions that are realistically adoptable in underserved communities, where affordability, cultural fit, and delivery constraints can determine success.
Browse more opportunities from the same category: Health
Next opportunity: 2017 Survey and Clearance in Parwan/Baghlan 2 (Project 19)
Previous opportunity: Limited Competition: Research Resource for Human Organs and Tissues (U42)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA MD 17 001
Applicants also applied for:
Applicants who have applied for this opportunity (RFA MD 17 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42) Apply for RFA MD 17 002 Funding Number: RFA MD 17 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34) Apply for RFA MH 17 612 Funding Number: RFA MH 17 612 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33) Apply for RFA MH 17 606 Funding Number: RFA MH 17 606 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| High-End Instrumentation (HEI) Grant Program (S10) Apply for PAR 17 076 Funding Number: PAR 17 076 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33) Apply for RFA MH 17 604 Funding Number: RFA MH 17 604 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01) Apply for PAR 17 079 Funding Number: PAR 17 079 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Short Courses for Mental Health-Related Research Education (R25) Apply for PAR 17 082 Funding Number: PAR 17 082 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01) Apply for RFA MH 17 614 Funding Number: RFA MH 17 614 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Mentoring Networks for Mental Health Research Education (R25) Apply for PAR 17 080 Funding Number: PAR 17 080 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIMH Research Education Programs for Psychiatry Residents (R25) Apply for PAR 17 081 Funding Number: PAR 17 081 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Eradication of HIV-1 from Central Nervous system Reservoirs (R01) Apply for PA 17 084 Funding Number: PA 17 084 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIBIB Biomedical Technology Resource Centers (P41) Apply for PAR 17 083 Funding Number: PAR 17 083 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Request for Comment on USAID's Burma Planned Maternal, Neonatal, and Child Health-Health Systems Strengthening (MNCH-HSS) activity Apply for RFI 17 MNCH ACTIVITY BURMA Funding Number: RFI 17 MNCH ACTIVITY BURMA Agency: Burma USAID - Rangoon Category: Health Funding Amount: $30,000,000 |
| Exploratory Analyses of Existing Cohorts, Data Sets, and Stored Biospecimens to Address Clinical Aging Research Questions (R21) Apply for PA 17 089 Funding Number: PA 17 089 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Secondary Analyses of Existing Cohorts, Data Sets and Stored Biospecimens to Address Clinical Aging Research Questions (R01) Apply for PA 17 088 Funding Number: PA 17 088 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maximizing Investigators' Research Award (R35) Apply for PAR 17 094 Funding Number: PAR 17 094 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Planning for Non-Communicable Diseases and Disorders Research Training Programs in Low and Middle Income Countries (D71) Apply for PAR 17 097 Funding Number: PAR 17 097 Agency: National Institutes of Health Category: Health Funding Amount: $46,000 |
| NEI Translational Research Program (TRP) to Develop Novel Therapies and Devices for the Treatment of Visual System Disorders (R24) Apply for PAR 17 099 Funding Number: PAR 17 099 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| National Centers for Cryoelectron Microscopy (U24) Apply for RFA RM 17 002 Funding Number: RFA RM 17 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Efficacy Clinical Trials (U01) Apply for PAR 17 102 Funding Number: PAR 17 102 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA MD 17 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.